China's drug safety agency has suspended sales of Methotrexate, a drug used to treat acute leukemia and rheumatoid arthritis.
Sales of methotrexate produced by Shanghai Hualian Pharmaceutical Co. Ltd. have been suspended because it caused an adverse reaction in several child leukemia patients in three hospitals in Shanghai and the southern province of Guangxi.
Some children felt pain in their legs while others experienced difficulty in walking after being injected with methotrexate numbered 070403A and 070403B.
Source: Reuters
http://www.reuters.com/article/healthNews/idUSPEK1476920070707
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment